Cost-effectiveness of enhanced liver fibrosis test to assess liver fibrosis in chronic hepatitis C virus and alcoholic liver disease patients

doi:10.3748/wjg.v23.i17.3163

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 23, Issue 17

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7688)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series, Tables (1-4) series.

Item

Count

PDF

672

WORD

428

HTML

3822

Figures (1-4)

164

Tables (1-4)

142

Sum=5228

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1010

Download

1446

Sum=2456

May 7, 2017 (publication date) through May 2, 2024

Times Cited of This Article

Times Cited (21)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Prospective Study

World J Gastroenterol. May 7, 2017; 23(17): 3163-3173
Published online May 7, 2017. doi: 10.3748/wjg.v23.i17.3163

Open in New Tab Full Size Figure Download Figure

Figure 1 Markov models for hepatitis C virus (A) and alcoholic liver disease (B).

Open in New Tab Full Size Figure Download Figure

Figure 2 Deterministic sensitivity analysis for hepatitis C virus. HCV: Hepatitis C virus; QALY: Quality-adjusted life year; ELF: Enhanced liver fibrosis test; LSM: Liver stiffness measurement; HCC: Hepatocellular carcinoma.

Open in New Tab Full Size Figure Download Figure

Figure 3 Deterministic sensitivity analysis for alcoholic liver disease. ALD: Alcoholic liver disease; QALY: Quality-adjusted life year; ELF: Enhanced liver fibrosis test; LSM: Liver stiffness measurement.

Open in New Tab Full Size Figure Download Figure

Figure 4 Cost-effectiveness acceptability curves in hepatitis C virus and alcoholic liver disease. HCV: Hepatitis C virus; ALD: Alcoholic liver disease; QALY: Quality-adjusted life year; ELF: Enhanced liver fibrosis test; LSM: Liver stiffness measurement.

Citation: Soto M, Sampietro-Colom L, Lasalvia L, Mira A, Jiménez W, Navasa M. Cost-effectiveness of enhanced liver fibrosis test to assess liver fibrosis in chronic hepatitis C virus and alcoholic liver disease patients. World J Gastroenterol 2017; 23(17): 3163-3173
URL: https://www.wjgnet.com/1007-9327/full/v23/i17/3163.htm
DOI: https://dx.doi.org/10.3748/wjg.v23.i17.3163